Classically, the study of pharmacokinetics (PK) has centered on hepatic metabolism and renal excretion as the primary ...

Cartel Expert Becomes First Woman to Lead Nation’s Drug Control Policy Today, in a 52-48 vote, United States Senate confirmed Sara Carter as the 10 th Director of the White House Office of National ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation's drug ...

Medicare has completed its second round of price negotiations for 15 top-selling prescription drugs and posted maximum fair prices, per an Inflation Reduction Act provision. The announced net prices, ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

The U.S. has revealed price reductions for the second round of prescription drugs negotiated by the Centers for Medicare & Medicaid Services (CMS) through the Inflation Reduction Act (IRA). Headlining ...

The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under Medicare, including Ozempic and Wegovy. The price cuts come through the Medicare ...

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ...

President Donald Trump announced a deal Thursday, Nov. 6 with drugmakers Eli Lilly and Novo Nordisk to cut prices of their popular weight-loss drugs and expand Medicare coverage of these medications ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money. By ...